JP2004503519A5 - - Google Patents

Download PDF

Info

Publication number
JP2004503519A5
JP2004503519A5 JP2002510422A JP2002510422A JP2004503519A5 JP 2004503519 A5 JP2004503519 A5 JP 2004503519A5 JP 2002510422 A JP2002510422 A JP 2002510422A JP 2002510422 A JP2002510422 A JP 2002510422A JP 2004503519 A5 JP2004503519 A5 JP 2004503519A5
Authority
JP
Japan
Prior art keywords
formula
salt
solvate
embedded image
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002510422A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004503519A (ja
Filing date
Publication date
Priority claimed from GBGB0014546.6A external-priority patent/GB0014546D0/en
Application filed filed Critical
Publication of JP2004503519A publication Critical patent/JP2004503519A/ja
Publication of JP2004503519A5 publication Critical patent/JP2004503519A5/ja
Pending legal-status Critical Current

Links

JP2002510422A 2000-06-14 2001-06-13 サルメテロールの新規な調製方法 Pending JP2004503519A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0014546.6A GB0014546D0 (en) 2000-06-14 2000-06-14 A novel process
PCT/GB2001/002624 WO2001096278A2 (en) 2000-06-14 2001-06-13 A novel process for preparing salmeterol

Publications (2)

Publication Number Publication Date
JP2004503519A JP2004503519A (ja) 2004-02-05
JP2004503519A5 true JP2004503519A5 (enExample) 2008-03-27

Family

ID=9893647

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002510422A Pending JP2004503519A (ja) 2000-06-14 2001-06-13 サルメテロールの新規な調製方法

Country Status (6)

Country Link
US (2) US6911560B2 (enExample)
EP (1) EP1289926A2 (enExample)
JP (1) JP2004503519A (enExample)
AU (1) AU2001264119A1 (enExample)
GB (1) GB0014546D0 (enExample)
WO (1) WO2001096278A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0315720A (pt) 2002-10-28 2005-09-06 Glaxo Group Ltd Composto, método para a profilaxia ou tratamento de uma condição clìnica em um mamìmefero, formulação farmacêutica, combinação, uso de um composto, processo para a preparação de um composto, e, intermediário
AU2006303124B2 (en) * 2005-10-17 2013-03-28 Generics [Uk] Limited Novel process
CN102584608B (zh) * 2011-01-06 2014-11-19 上海医药工业研究院 α-(氨甲基)-4-羟基-1,3-苯二甲醇的制备方法及其中间体
US9447067B2 (en) * 2014-10-03 2016-09-20 Amphastar Pahmaceuticals, Inc. Method of preparing intermediate of salmeterol
CN105884625B (zh) * 2016-05-10 2018-11-13 浙江工业大学 一种r-沙美特罗的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW6584A1 (en) 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
IL95936A (en) * 1989-10-10 1996-01-19 Glaxo Group Ltd ) R (-) - (- Hydroxy- (A-]]] 6-) 4- Phenylbutoxy (xyl [amino] methyl [-1,3-benzenedimethanol, its preparation and pharmaceutical preparations containing it
AT399874B (de) 1990-06-05 1995-08-25 Glaxo Group Ltd Dichloranilinverbindung

Similar Documents

Publication Publication Date Title
JP2005053931A5 (enExample)
JP2007511546A5 (enExample)
RU2001124567A (ru) Производные индола и их применение в качестве антагонистов мср-1
JP7761578B2 (ja) シクロスポリン誘導体の調製
JP2005519083A5 (enExample)
JP2005526836A5 (enExample)
HUP0303756A2 (hu) 1-Aril- vagy 1-alkilszulfonil-heterociklobenzazolok és eljárás ezek elõállítására és ezeket tartalmazó gyógyszerkészítmények
WO2005051946A3 (en) Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
JP2003520235A5 (enExample)
EP1829858A3 (en) Dibenzylamine compounds and pharmaceutical use thereof
JP2003519207A5 (enExample)
JP2011519910A5 (enExample)
RU2000128658A (ru) Тиенилазолилалкоксиэтанамны, их производные и их применение в качестве лекарственных средств
JP2005536503A5 (enExample)
CA2515940A1 (en) Substituted heterocycles
CA2511255A1 (en) 2-piperidone derivatives as prostaglandin agonists
JP2005517657A5 (enExample)
RU97102362A (ru) Нейрозащитные производные 3-(пиперидинил-1)-хроман-4,7-диола и 1-(4- гидроксифенил)-2-(пиперидинил-1)-алканола
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
JP2009533417A5 (enExample)
JP2004529172A5 (enExample)
JP2005506354A5 (enExample)
JP2010509334A5 (enExample)
JP2004503519A5 (enExample)
JP2002506844A5 (enExample)